NCT07138209 2026-02-27A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple MyelomaQilu Pharmaceutical Co., Ltd.Phase 3 Recruiting228 enrolled